InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,482.87
(
0.09%
)
US TECH 100
19,264.40
(
0.00%
)
Dow Jones
39,164.06
(
0.09%
)
Brent Oil
85.82
(
0.47%
)
Bitcoin
61,480.33
(
-0.22%
)
Post# of 252412
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ghmm

Send PM Follow Ignore
Followers 50
Posts 6343
Boards Moderated 0
Alias Born 01/22/2006

ghmm

Re: DewDiligence post# 45143

Monday, 04/16/2007 4:00:44 AM

Monday, April 16, 2007 4:00:44 AM

Post# of 252412
GPC/SPPI:

There wasn’t any reason to think they would get a standard review, and an RTF was out of the question.

Since Cardiome/Astellas botched their filing I never take it for granted.

An interesting debate which drug has higher 2008 revenue Satraplatin or Provenge, especially if you thinks an approvable may be in one drug but not the others future.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up